Markush pharma patent claims supported by Beijing Higher People’s Court
A recent decision in China provides some assurance for pharmaceutical patent owners but the direction of Markush claims is still unclear
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: